116 related articles for article (PubMed ID: 10214700)
1. Hemoabzymes. Different strategies for obtaining artificial hemoproteins based on antibodies.
Mahy JP; Desfosses B; de Lauzon S; Quilez R; Desfosses B; Lion L; Mansuy D
Appl Biochem Biotechnol; 1998 Oct; 75(1):103-27. PubMed ID: 10214700
[TBL] [Abstract][Full Text] [Related]
2. Hemoabzymes: towards new biocatalysts for selective oxidations.
Ricoux R; Sauriat-Dorizon H; Girgenti E; Blanchard D; Mahy JP
J Immunol Methods; 2002 Nov; 269(1-2):39-57. PubMed ID: 12379351
[TBL] [Abstract][Full Text] [Related]
3. Active site topology of artificial peroxidase-like hemoproteins based on antibodies constructed from a specifically designed ortho-carboxy-substituted tetraarylporphyrin.
De Lauzon S; Quilez R; Lion L; Desfosses B; Desfosses B; Lee I; Sari MA; Benkovic SJ; Mansuy D; Mahy JP
Eur J Biochem; 1998 Oct; 257(1):121-30. PubMed ID: 9799110
[TBL] [Abstract][Full Text] [Related]
4. Artificial peroxidase-like hemoproteins based on antibodies constructed from a specifically designed ortho-carboxy substituted tetraarylporphyrin hapten and exhibiting a high affinity for iron-porphyrins.
Quilez R; de Lauzon S; Desfosses B; Mansuy D; Mahy JP
FEBS Lett; 1996 Oct; 395(1):73-6. PubMed ID: 8849692
[TBL] [Abstract][Full Text] [Related]
5. Studies of the reactivity of artificial peroxidase-like hemoproteins based on antibodies elicited against a specifically designed ortho-carboxy substituted tetraarylporphyrin.
de Lauzon S; Desfosses B; Mansuy D; Mahy JP
FEBS Lett; 1999 Jan; 443(2):229-34. PubMed ID: 9989611
[TBL] [Abstract][Full Text] [Related]
6. From "hemoabzymes" to "hemozymes": towards new biocatalysts for selective oxidations.
Mahy JP; Maréchal JD; Ricoux R
Chem Commun (Camb); 2015 Feb; 51(13):2476-94. PubMed ID: 25493292
[TBL] [Abstract][Full Text] [Related]
7. Hemozymes peroxidase activity of artificial hemoproteins constructed from the Streptomyces lividans xylanase A and iron(III)-carboxy-substituted porphyrins.
Ricoux R; Dubuc R; Dupont C; Marechal JD; Martin A; Sellier M; Mahy JP
Bioconjug Chem; 2008 Apr; 19(4):899-910. PubMed ID: 18324756
[TBL] [Abstract][Full Text] [Related]
8. Resonance Raman studies on the ligand-iron interactions in hemoproteins and metallo-porphyrins.
Kitagawa T; Ozaki Y; Kyogoku Y
Adv Biophys; 1978; 11():153-96. PubMed ID: 27953
[TBL] [Abstract][Full Text] [Related]
9. Coordination chemistry of iron(III)-porphyrin-antibody complexes.
de Lauzon S; Mansuy D; Mahy JP
Eur J Biochem; 2002 Jan; 269(2):470-80. PubMed ID: 11856305
[TBL] [Abstract][Full Text] [Related]
10. Cobalt(IV) corroles as catalysts for the electroreduction of O2: reactions of heterobimetallic dyads containing a face-to-face linked Fe(III) or Mn(III) porphyrin.
Kadish KM; Frémond L; Burdet F; Barbe JM; Gros CP; Guilard R
J Inorg Biochem; 2006 Apr; 100(4):858-68. PubMed ID: 16516296
[TBL] [Abstract][Full Text] [Related]
11. New activities of a catalytic antibody with a peroxidase activity: formation of Fe(II)-RNO complexes and stereoselective oxidation of sulfides.
Ricoux R; Lukowska E; Pezzotti F; Mahy JP
Eur J Biochem; 2004 Apr; 271(7):1277-83. PubMed ID: 15030477
[TBL] [Abstract][Full Text] [Related]
12. Apigenin-7-O-glucoside oxidation catalyzed by P450-bioinspired systems.
Bolzon LB; Dos Santos JS; Silva DB; Crevelin EJ; Moraes LA; Lopes NP; Assis MD
J Inorg Biochem; 2017 May; 170():117-124. PubMed ID: 28236787
[TBL] [Abstract][Full Text] [Related]
13. μ-Nitrido Diiron Macrocyclic Platform: Particular Structure for Particular Catalysis.
Afanasiev P; Sorokin AB
Acc Chem Res; 2016 Apr; 49(4):583-93. PubMed ID: 26967682
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics.
Tovmasyan A; Maia CG; Weitner T; Carballal S; Sampaio RS; Lieb D; Ghazaryan R; Ivanovic-Burmazovic I; Ferrer-Sueta G; Radi R; Reboucas JS; Spasojevic I; Benov L; Batinic-Haberle I
Free Radic Biol Med; 2015 Sep; 86():308-21. PubMed ID: 26026699
[TBL] [Abstract][Full Text] [Related]
15. Pyridoxal-5'-phosphate-dependent catalytic antibodies.
Gramatikova S; Mouratou B; Stetefeld J; Mehta PK; Christen P
J Immunol Methods; 2002 Nov; 269(1-2):99-110. PubMed ID: 12379355
[TBL] [Abstract][Full Text] [Related]
16. A proton-shuttle mechanism mediated by the porphyrin in benzene hydroxylation by cytochrome p450 enzymes.
de Visser SP; Shaik S
J Am Chem Soc; 2003 Jun; 125(24):7413-24. PubMed ID: 12797816
[TBL] [Abstract][Full Text] [Related]
17. Porphyrin-Fe(III)-hydroperoxide and porphyrin-Fe(III)-peroxide anion as catalytic intermediates in cytochrome P450-catalyzed hydroxylation reactions: a molecular orbital study.
Zakhariev O; Trautwein AX; Veeger C
Biophys Chem; 2000 Dec; 88(1-3):11-34. PubMed ID: 11152267
[TBL] [Abstract][Full Text] [Related]
18. Peroxidation of Pyrogallol by Antibody-Metalloporphyrin Complexes.
Harada A; Fukushima H; Shiotsuki K; Yamaguchi H; Oka F; Kamachi M
Inorg Chem; 1997 Dec; 36(26):6099-6102. PubMed ID: 11670246
[TBL] [Abstract][Full Text] [Related]
19. Chemical properties of water-soluble porphyrins. 5. Reactions of some manganese (III) porphyrins with the superoxide and other reducing radicals.
Weinraub D; Levy P; Faraggi M
Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Oct; 50(4):649-58. PubMed ID: 3019912
[TBL] [Abstract][Full Text] [Related]
20. Effect of porphyrin ligands on the regioselective dehydrogenation versus epoxidation of olefins by oxoiron(IV) mimics of cytochrome P450.
Kumar D; Tahsini L; de Visser SP; Kang HY; Kim SJ; Nam W
J Phys Chem A; 2009 Oct; 113(43):11713-22. PubMed ID: 19658379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
